- Eplerenone2007 | First Faculty of Medicine
- History of hypertension and eplerenone in patients with acute myocardial infarction complicated by heart failure2008 | First Faculty of Medicine
- Final report of University Hospital Hradec Kralove to the clinical trial protocol no. A6141116Publication without faculty affiliation
- Eplerenon u kardiovaskulárních onemocnění2016 | First Faculty of Medicine
- Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms2011 | First Faculty of Medicine, Third Faculty of Medicine
- Revival of aldosterone blockers in the treatment of chronic heart failure and results of the EMPHASIS-HF study2011 | First Faculty of Medicine
- Eplerenone reduces mortality 30 days after randomization following acute myocardial infarction in patients with left ventricular systolic dysfunction and heart failure2005 | First Faculty of Medicine
- Eplerenone reduces mortality 30 days after randomization following acute myocardial infarction in patients with left ventricular systolic dysfunction and heart failure2005 | Faculty of Physical Education and Sport
- The EPHESUS trial: Effect of eplerenone in patients with a baseline history of hypertensionPublication without faculty affiliation
- Spironolactone - renesance of the old treatment strategy2005 | First Faculty of Medicine
- Spironolactone - renesance of the old treatment strategy2005 | Faculty of Physical Education and Sport
- What is new in diagnostics and treatment of heart failure?2011 | First Faculty of Medicine
- New trends in management of heart failure2004 | Third Faculty of Medicine
- Antagonists of the renin-angiotensin-aldosterone system2011 | First Faculty of Medicine
- Novinky v léčbě rezistentní hypertenze2019 | First Faculty of Medicine
- Adherence and blood pressure control in patients with primary aldosteronism2022 | First Faculty of Medicine, Third Faculty of Medicine
- Should All Patients with Resistant Hypertension Receive Spironolactone?2016 | First Faculty of Medicine, Third Faculty of Medicine
- Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction: the DIAMOND trial2022 | Publication without faculty affiliation
- An international collaborative evaluation of central serous chorioretinopathy: different therapeutic approaches and review of literature. The European Vitreoretinal Society central serous chorioretinopathy studyPublication without faculty affiliation